Drug distributor backs fiscal 2024 profit guidance despite end of contract that generated 16% of its revenue last year.
Cardinal Health’s stock falls after company says contract with OptumRx will not be renewed after June
Read Next
- How Much of My Paycheck Should I Save?
- GM killing Cadillac XT6, extending production of XT5 in Tennessee
- U.S. financial regulator says email hack exposed sensitive bank data
- Exclusive: IG Group partnerships head Alex Ratford departs
- Mortgage rates slingshot higher as tariff uncertainty roils markets
- Broadridge launches Broadridge Digital Assets Solutions
- Centroid partners with Nelogica’s BlackArrow trading platform
